08.11.26 -- June 2026 — CDMO Opportunities And Threats Report

Discover an autoinjector platform that supports ANDA pathways with demonstrated usability and design alignment to help development teams reduce risk and move confidently toward regulatory submission.

See how incorporating small amounts of mesoporous silica during micronization can significantly enhance powder flow, thereby making blending and formulation more efficient and consistent.

As deep space missions return, new research is uncovering how human biology adapts beyond Earth. Advanced tissue models offer fresh insight into bone marrow response, opening new possibilities.

Move beyond reactive firefighting by prioritizing disciplined leadership and data-driven milestones. The winning model for complex programs is focused, high-maturity, low-drama execution.

Digital twin technology optimizes aseptic fill-finish through real-time mirroring and predictive simulation. Improve yields and validate complex recipes by integrating dynamic virtual models.

Enhance containment and process reliability in oral GLP-1 synthesis. Find out how integrated single-use assemblies and automated fluidics safeguard chemical purity during scale-up.

Transition from periodic sampling to continuous monitoring. Learn to establish risk-based alert limits and use N:M trending to maintain a true state of control in critical cleanroom zones.

Explore how this patented Wittig-based process for olopatadine HCl achieves Z/E isomer ratios up to 4:1, eliminating dangerous reagents like n-butyl lithium while cutting purification complexity.

Integrating AI into regulated workflows requires robust risk-based validation, human oversight, and data integrity to ensure compliance with evolving global regulatory frameworks.

Aligning compounding operations with USP <797> and <800> requires an integrated control strategy. Gain insight into key criteria for cleanroom equipment selection.

Hear from experienced professionals in the drug delivery space on how to ensure success and speed-to-market by establishing a firm foundation when working with a CMO.

Optimizing L-Leucine balances porosity and surface enrichment in spray-dried formulations. Precise adjustments alter particle structure to enhance aerodynamic performance and lung deposition.

Drug manufacturers seek packaging that maintains integrity during processing and freezing, scales up to larger volumes easily, and remains robust throughout the temperature-controlled supply chain.

Antibody aggregation remains a critical downstream challenge, particularly for complex modalities. Take a look at why aggregates form, why they matter, and how chromatographic strategies can help.

Platforms incorporating high throughput in silico screening, in vitro expression, and immunosafety of multi-specific molecules can help mitigate potential developability risks and accelerate timelines.

Examine the calculation of Overall Equipment Effectiveness (OEE) and the impact of product inspection equipment on OEE in the pharmaceutical industry.

Tight timelines and coordinated packaging execution drove a high-stakes product launch ahead of a national competitor, ultimately capturing over half the market and setting a new benchmark.

IoT-enabled smart BMS modernize cleanrooms through continuous monitoring, predictive analytics, energy efficiency, and strengthened regulatory compliance, enabling safer, more efficient operations.

New drug modalities are transforming treatment but bring new challenges. Observe how hybrid approaches that combine biologics and chemistry are redefining the design of innovative therapies.